The
MHRA have issued some guidance for the implementation of Good Distribution
Practices (GDP). This follows a recent update to EU guidance.
According
to the Agency:
“Following
publication of the revised Guidelines for GDP by the European Commission, the
following explanatory note has been prepared in order to clarify the
interpretation of the guideline by MHRA. The document is not intended to
provide an in depth explanation of the published guideline, and should be read
in conjunction with the guide, in order to clarify the expectations of the MHRA
Inspectorate for those areas that may be open to individual Member State
interpretation.”
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources